| 24900670 |
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Gao, W,
End, P,
Pan, S,
Mi, Y,
Tuntland, T,
Heining, P,
Gardin, A,
Hinterding, K,
Fan, Y,
Lefebvre, S,
Cooke, NG,
Chen, Y,
Bruns, C,
Chu, A,
Gray, NS,
Nuesslein-Hildesheim, B,
Wang, X,
Che, J
|
ACS Med Chem Lett |
2013 |
| 26990079 |
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity
Scott, FL,
Rosen, H,
Brooks, J,
Roberts, E,
Martinborough, E,
Brahmachary, E,
Desale, HG,
Timony, GA,
Clemons, B,
Peach, RJ,
Boehm, MF,
Dedman, H,
Powell, R
|
Br J Pharmacol |
2016 |
| 29735753 |
Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism
Camenisch, G,
Jin, Y,
Meissner, A,
Nufer, R,
Li, W,
Legangneux, E,
Borell, H,
Adam-Stitah, S,
Peter van Marle, S,
Gardin, A,
James, AD,
Schroer, K,
Glaenzel, U
|
Drug Metab. Dispos. |
2018 |
